These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25003978)

  • 1. A microfluidic method to synthesize transferrin-lipid nanoparticles loaded with siRNA LOR-1284 for therapy of acute myeloid leukemia.
    Yang Z; Yu B; Zhu J; Huang X; Xie J; Xu S; Yang X; Wang X; Yung BC; Lee LJ; Lee RJ; Teng L
    Nanoscale; 2014 Aug; 6(16):9742-51. PubMed ID: 25003978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia.
    Huang X; Schwind S; Yu B; Santhanam R; Wang H; Hoellerbauer P; Mims A; Klisovic R; Walker AR; Chan KK; Blum W; Perrotti D; Byrd JC; Bloomfield CD; Caligiuri MA; Lee RJ; Garzon R; Muthusamy N; Lee LJ; Marcucci G
    Clin Cancer Res; 2013 May; 19(9):2355-67. PubMed ID: 23493348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice.
    Yhee JY; Lee SJ; Lee S; Song S; Min HS; Kang SW; Son S; Jeong SY; Kwon IC; Kim SH; Kim K
    Bioconjug Chem; 2013 Nov; 24(11):1850-60. PubMed ID: 24107100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Polyethylenimine-Containing and Transferrin-Conjugated Lipid Nanoparticle System for Antisense Oligonucleotide Delivery to AML.
    Yuan Y; Zhang L; Cao H; Yang Y; Zheng Y; Yang XJ
    Biomed Res Int; 2016; 2016():1287128. PubMed ID: 27034925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia.
    Jin Y; Liu S; Yu B; Golan S; Koh CG; Yang J; Huynh L; Yang X; Pang J; Muthusamy N; Chan KK; Byrd JC; Talmon Y; Lee LJ; Lee RJ; Marcucci G
    Mol Pharm; 2010 Feb; 7(1):196-206. PubMed ID: 19852511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
    Zhu B; Zhang H; Yu L
    Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of Antisense Oligonucleotide LOR-2501 Using Transferrin-conjugated Polyethylenimine-based Lipid Nanoparticle.
    Zheng B; Yang S; Tian Q; Xie Y; Zhang S; Lee RJ
    Anticancer Res; 2019 Apr; 39(4):1785-1793. PubMed ID: 30952718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-step microfluidic synthesis of transferrin-conjugated lipid nanoparticles for siRNA delivery.
    Li Y; Lee RJ; Huang X; Li Y; Lv B; Wang T; Qi Y; Hao F; Lu J; Meng Q; Teng L; Zhou Y; Xie J; Teng L
    Nanomedicine; 2017 Feb; 13(2):371-381. PubMed ID: 27720989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
    Nag M; Gajbhiye V; Kesharwani P; Jain NK
    Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-Step Self-Assembling Method to Prepare Dual-Functional Transferrin Nanoparticles for Antitumor Drug Delivery.
    Wang K; Yuan A; Yu J; Wu J; Hu Y
    J Pharm Sci; 2016 Mar; 105(3):1269-76. PubMed ID: 26886339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
    Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
    Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia.
    Li H; Xu S; Quan J; Yung BC; Pang J; Zhou C; Cho YA; Zhang M; Liu S; Muthusamy N; Chan KK; Byrd JC; Lee LJ; Marcucci G; Lee RJ
    Mol Pharm; 2015 Jun; 12(6):2010-8. PubMed ID: 25871632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-viral nano-delivery system targeting epigenetic methyltransferase EZH2 for precise acute myeloid leukemia therapy.
    Kaundal B; Kushwaha AC; Srivastava AK; Karmakar S; Choudhury SR
    J Mater Chem B; 2020 Sep; 8(37):8658-8670. PubMed ID: 32844866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
    Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
    J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin.
    Khajavinia A; Varshosaz J; Dehkordi AJ
    Nanotechnology; 2012 Oct; 23(40):405101. PubMed ID: 22983592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells.
    Wang X; Huang X; Yang Z; Gallego-Perez D; Ma J; Zhao X; Xie J; Nakano I; Lee LJ
    Curr Pharm Biotechnol; 2014; 15(9):839-46. PubMed ID: 25374033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
    Tan S; Wang G
    Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.